BEAM THERAPEUTICS INC (BEAM) Forecast, Price Target & Analyst Ratings

NASDAQ:BEAMUS07373V1052

Current stock price

24.63 USD
-0.54 (-2.15%)
At close:
24.63 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BEAM THERAPEUTICS INC (BEAM).

Forecast Snapshot

Consensus Price Target

Price Target
$49.10
+ 99.35% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.11
Revenue Estimate
11.642M

ChartMill Buy Consensus

Rating
86.40%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$49.10
Upside
+ 99.35%
From current price of $24.63 to mean target of $49.10, Based on 25 analyst forecasts
Low
$22.22
Median
$45.90
High
$84.00

Price Target Revisions

1 Month
3.47%
3 Months
6.18%

Price Target Summary

25 Wall Street analysts provided a forecast for the next 12 months for BEAM. The average price target is 49.1 USD. This implies a price increase of 99.35% is expected in the next year compared to the current price of 24.63.
The average price target has been revised upward by 6.18% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

BEAM Current Analyst RatingBEAM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

BEAM Historical Analyst RatingsBEAM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
86.40%
BEAM was analyzed by 25 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BEAM.
In the previous month the buy percentage consensus was at a similar level.
BEAM was analyzed by 25 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-25RBC CapitalMaintains Sector Perform -> Sector Perform
2026-02-25WedbushMaintains Outperform -> Outperform
2026-02-20Canaccord GenuityInitiate Buy
2026-01-21BernsteinMaintains Outperform -> Outperform
2026-01-07UBSInitiate Neutral
2025-11-24Evercore ISI GroupInitiate Outperform
2025-10-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-06BarclaysMaintains Equal-Weight -> Equal-Weight
2025-05-07GuggenheimMaintains Buy -> Buy
2025-05-07BarclaysMaintains Equal-Weight -> Equal-Weight
2025-05-07Wells FargoMaintains Overweight -> Overweight
2025-04-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-28B of A SecuritiesUpgrade Neutral -> Buy
2025-03-12Cantor FitzgeraldReiterate Overweight -> Overweight
2025-03-10Jones TradingUpgrade Hold -> Buy
2025-03-10ScotiaBankUpgrade Sector Perform -> Sector Outperform
2025-03-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-03ScotiaBankMaintains Sector Perform -> Sector Perform
2025-02-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-27GuggenheimReiterate Buy -> Buy
2025-02-26RBC CapitalMaintains Sector Perform -> Sector Perform
2025-02-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-29Cantor FitzgeraldUpgrade Neutral -> Overweight
2024-12-09HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.11
Revenue Estimate
11.642M
Revenue Q2Q
55.85%
EPS Q2Q
10.37%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-21.25%
Revenue (3 Months)
-26.92%
EPS (1 Month)
7.30%
EPS (3 Months)
7.47%

Next Earnings Summary

BEAM is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -1.11 USD and the consensus revenue estimate is 11.64M USD.
The next earnings revenue estimate has been revised downward by 26.92% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BEAM revenue by date.BEAM revenue by date.
377.709M
520.01%
63.518M
-83.18%
139.743M
120.01%
48.28M
-65.45%
65.565M
35.80%
137.11M
109.12%
379.92M
177.09%
817.39M
115.15%
996.7M
21.94%
1.341B
34.54%
1.787B
33.26%
EBITDA
YoY % growth
BEAM ebitda by date.BEAM ebitda by date.
-156.473M
51.76%
-393.643M
-151.57%
-361.399M
8.19%
-496.179M
-37.29%
-522.339M
-5.27%
-416.16M
20.33%
-268.872M
35.39%
-198.696M
26.10%
-96.492M
51.44%
N/AN/A
EBIT
YoY % growth
BEAM ebit by date.BEAM ebit by date.
-176.485M
47.86%
-415.568M
-135.47%
-383.693M
7.67%
-551.289M
-43.68%
-585.474M
-6.20%
-563.683M
3.72%
-453.663M
19.52%
-272.778M
39.87%
36.668M
113.44%
100.11M
173.02%
400.25M
299.81%
Operating Margin
BEAM operating margin by date.BEAM operating margin by date.
-46.73%-654.25%-274.57%-1,141.86%-892.97%-411.12%-119.41%-33.37%3.68%7.47%22.40%
EPS
YoY % growth
BEAM eps by date.BEAM eps by date.
-1.90
54.00%
-4.58
-141.05%
-3.44
24.83%
-4.67
-35.55%
-4.72
-1.23%
-4.38
7.20%
-3.53
19.45%
-1.69
52.24%
0.99
158.39%
2.16
119.12%
4.40
103.97%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.11
10.37%
-1.17
-16.98%
-1.29
-17.53%
-1.28
-1,139.52%
-1.85
-66.48%
-1.95
-66.98%
-1.86
-43.76%
-1.77
-39.01%
Revenue
Q2Q % growth
11.642M
55.85%
11.876M
40.28%
15.033M
55.01%
18.087M
-84.15%
9.892M
-15.03%
9.892M
-16.71%
9.892M
-34.20%
21.469M
18.70%
EBITDA
Q2Q % growth
-108.395M
4.71%
-123.794M
-13.48%
-142.821M
-29.62%
-88.23M
-1,919.55%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-111.804M
6.27%
-120.475M
-0.27%
-104.533M
17.57%
-133.62M
-665.95%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BEAM Yearly Revenue VS EstimatesBEAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
BEAM Yearly EPS VS EstimatesBEAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-8.39%
EPS Next 5 Year
8.59%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
51.98%
Revenue Next 5 Year
83.72%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
5.41%
EBIT Next 5 Year
9.92%

BEAM THERAPEUTICS INC / BEAM Forecast FAQ

What is the average price target for BEAM THERAPEUTICS INC (BEAM) stock?

25 analysts have analysed BEAM and the average price target is 49.1 USD. This implies a price increase of 99.35% is expected in the next year compared to the current price of 24.63.

Can you provide the upcoming earnings date for BEAM THERAPEUTICS INC?

BEAM THERAPEUTICS INC (BEAM) will report earnings on 2026-05-04.

Can you provide the consensus estimates for BEAM THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of BEAM THERAPEUTICS INC (BEAM) is -1.11 USD and the consensus revenue estimate is 11.64M USD.

What is the expected long term growth rate for BEAM stock?

The expected long term growth rate for BEAM THERAPEUTICS INC (BEAM) is 51.98%.